15 Jul 2019 - Singapore Business Review
Its customer Illumina is expected to grow 6%, albeit at a lower rate compared to its previous estimate of 13-14%. Venture Corporation’s test & measurement, medical devices, and life science segments are expected to drive the firm’s next growth phase in H2, according to a report by DBS Equity Research. ...
sgx:v03